Lymphatic vasculature and sentinel lymph node tissue

The lymphatic vasculature and sentinel lymph node tissue constitute a complex network of vessels and lymphoid organs responsible for maintaining fluid homeostasis and facilitating immune surveillance. In oncology, the sentinel lymph node is defined as the first lymph node(s) to which cancer cells are most likely to spread from a primary tumor, making it a critical site for detecting early metastasis (National Cancer Institute, 2023). This system is not a single molecular target but an anatomical region targeted by diagnostic agents to map cancer spread. Key molecular markers within this tissue include lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and Podoplanin, which are used to distinguish lymphatic vessels from blood vessels (UniProt, 2024). Drugs such as Technetium Tc 99m tilmanocept interact with specific receptors like CD206 within the lymph nodes to provide precise localization (FDA, 2013). Therapeutic strategies also involve using the lymphatic route for vaccine delivery and treating inflammatory conditions. Understanding the physiology of this tissue is essential for managing lymphedema and preventing the systemic spread of infections. Overall, it serves as a vital conduit for both physiological transport and pathological progression.

Other names

Lymphatic systemLymphatic networkSentinel lymph nodesLymphatic vessels

Diagnostic mapping via lymphatic drainage and receptor-mediated uptake (e.g., CD206 binding)